Kirin Settles Suit Vs. Geron Over Cancer Vaccine Development Rights

Law360, New York (June 22, 2004, 12:00 AM EDT) -- Japanese pharmaceutical and brewing company Kirin Brewery has settled its litigation against Geron Corp. over development rights to cancer vaccines.

The lawsuit has been dismissed, and the out-of-court settlement does not involve any payment by either party, Geron said in a statement.

There will be no effect on the licensing agreement between Geron and Merix Bioscience, and Kirin has subsequently entered into a global partnership with Merix for research and development activity relating to cancer therapies.

Kirin will make a $5 million investment to buy a...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.